299 related articles for article (PubMed ID: 11319722)
1. Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus.
Kim DJ; Lee MS; Kim KW; Lee MK
Metabolism; 2001 May; 50(5):590-3. PubMed ID: 11319722
[TBL] [Abstract][Full Text] [Related]
2. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
[TBL] [Abstract][Full Text] [Related]
4. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
Weyer C; Bogardus C; Pratley RE
Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
[TBL] [Abstract][Full Text] [Related]
5. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
Salinitri FD; Pinelli NR; Martin ET; Jaber LA
Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects.
Kang HW; Kim DJ; Lee MS; Kim KW; Lee MK
Diabetes Res Clin Pract; 2005 Aug; 69(2):180-7. PubMed ID: 16005368
[TBL] [Abstract][Full Text] [Related]
7. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.
Meyer C; Pimenta W; Woerle HJ; Van Haeften T; Szoke E; Mitrakou A; Gerich J
Diabetes Care; 2006 Aug; 29(8):1909-14. PubMed ID: 16873801
[TBL] [Abstract][Full Text] [Related]
8. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
[TBL] [Abstract][Full Text] [Related]
9. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
10. Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.
Park KS; Park YJ; Kim SW; Shin CS; Park DJ; Koh JJ; Kim SY; Kim NK; Lee HK
Korean J Intern Med; 2000 Jan; 15(1):37-41. PubMed ID: 10714090
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
[TBL] [Abstract][Full Text] [Related]
12. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.
Dagogo-Jack S; Askari H; Tykodi G
J Clin Endocrinol Metab; 2009 Jun; 94(6):2031-6. PubMed ID: 19276238
[TBL] [Abstract][Full Text] [Related]
13. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
14. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
[TBL] [Abstract][Full Text] [Related]
15. Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation.
Qian L; Xu L; Wang X; Fu X; Gu Y; Lin F; Peng Y; Li G; Luo M
Diabetes Metab Res Rev; 2009 Feb; 25(2):144-9. PubMed ID: 19116942
[TBL] [Abstract][Full Text] [Related]
16. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
[TBL] [Abstract][Full Text] [Related]
17. Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT.
Abdul-Ghani MA; Sabbah M; Kher J; Minuchin O; Vardi P; Raz I
Diabetes Metab Res Rev; 2006; 22(2):126-30. PubMed ID: 16187399
[TBL] [Abstract][Full Text] [Related]
18. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
Festa A; D'Agostino R; Hanley AJ; Karter AJ; Saad MF; Haffner SM
Diabetes; 2004 Jun; 53(6):1549-55. PubMed ID: 15161760
[TBL] [Abstract][Full Text] [Related]
19. The effect of defective early phase insulin secretion on postload glucose intolerance in impaired fasting glucose.
Sargin M; Ikiişik M; Sargin H; Orçun A; Kaya M; Gözü H; Dabak R; Bayramiçli OU; Yayla A
Endocr J; 2005 Oct; 52(5):531-6. PubMed ID: 16284429
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
